Marinomed Biotech's Unattributed VC Round

Marinomed Biotech raised a round of funding on January 01, 2011. Investors include Arax Capital Partners.

Marinomed Biotech is focused on the discovery and development of therapies for respiratory diseases. The company has developed MAVIREX, a technology platform that targets more than 200 different virus…

Articles about Marinomed Biotech's Unattributed VC Round: